[EN] MACROCYCLIC TGF-BR2 KINASE INHIBITORS<br/>[FR] INHIBITEURS MACROCYCLIQUES DE LA KINASE TGF-BR2
申请人:ONCODESIGN SA
公开号:WO2015136073A1
公开(公告)日:2015-09-17
The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of Transforming Growth Factor beta Receptor 2 (TGF-β R2) and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of TGF-β R2 -kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.
本发明涉及大环化合物和含有该化合物的组合物,作为激酶抑制剂,特别是作为转化生长因子β受体2(TGF-β R2)及/或其突变体的抑制剂,用于诊断、预防和/或治疗TGF-β R2-激酶相关疾病。此外,本发明提供了使用该化合物的方法,例如作为药物或诊断试剂。